THE WHAT? Astorg-owned elements producer Solabia has introduced a strategic restructuring to strengthen its place in cosmetics, nutraceuticals and biotechnology, alongside the appointment of Muriel Koch as President and Chief Govt Officer.
THE DETAILS Solabia plans to divest its microbiology diagnostics division to Oxoid Remel Microbiology, one other Astorg portfolio firm, topic to regulatory approvals and definitive agreements. The transfer follows its acquisition of Mibelle Biochemistry in June 2026, strengthening its place in beauty energetic elements. Muriel Koch, previously CEO of Groupe NUXE, will take over on 29 October 2026, succeeding Jean-Baptiste Dellon, who led the corporate for 4 and a half years. The restructuring will focus sources on pure and biotechnology-derived energetic elements whereas supporting worldwide enlargement.
THE WHY? The strategic repositioning displays rising funding in science-backed beauty elements and the consolidation of specialist suppliers. By concentrating on its core markets and strengthening its management, Solabia goals to speed up innovation, develop its worldwide presence and reinforce its place inside the world magnificence elements trade.
Supply: astorg
